Open AccessImpact of non-invasive anatomical testing on optimal medical prescription in patients with suspected coronary artery disease
Author(s) -
Stijn Devuyst,
Arno Gigase,
Jerrold Spapen,
Sofie Brouwers,
Thomas Couck,
Jeroen Sonck,
Takuya Mizukami,
Carlo Gigante,
Herbert De Raedt,
Dan Schelfaut,
Ward Heggermont,
Bernard De Bruyne,
Martin Pěnička,
Guy Van Camp,
Carlos Collet
Publication year - 2019
Publication title -
cardiovascular diagnosis and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.83
H-Index - 22
eISSN - 2223-3660
pISSN - 2223-3652
DOI - 10.21037/cdt.2019.04.10
Subject(s) - medicine , coronary artery disease , aspirin , medical prescription , cardiology , statin , diabetes mellitus , radiology , pharmacology , endocrinology
Compared to functional testing, coronary computed tomography angiography (CTA) improves clinical outcomes in patients with suspected coronary artery disease (CAD). This is thought to be the result of an increased prescription of preventive medical therapy (statins and aspirin) when relying on a CTA imaging strategy. We compared the rate of statins prescription in a patient cohort assessed either with coronary CTA or exercise testing, and evaluated the agreement on medication prescriptions.